Core Viewpoint - The company's performance is currently under pressure due to internal and external factors, but there are expectations for the release of synergistic effects from integration [1] Investment Highlights - The company has adjusted its earnings expectations for 2025-2026 due to uncertainties in downstream consumption trends, with new earnings expectations for 2027. The projected EPS for 2025-2027 is 0.48, 0.60, and 0.73 yuan respectively, compared to previous estimates of 0.54 and 0.58 yuan for 2025-2026. The target price is set at 13.02 yuan based on an industry average valuation of 27.0X PE for 2025, maintaining a "buy" rating [2] - In Q1 2025, the company reported revenue of 358 million yuan, a year-on-year decrease of 18.18%. The net profit attributable to shareholders was 13 million yuan, down 75.01%, and the net profit after deducting non-recurring items was 11 million yuan, down 74.55%. Sales expenses increased by 57.49% to 12.57 million yuan, primarily due to stock incentive provisions. Tax and additional charges rose by 173.66% to 7.20 million yuan, mainly due to a large stamp duty from the acquisition of Funmei Packaging Co., Ltd. Financial expenses surged by 1392.72% to 20.80 million yuan, mainly due to increased interest expenses from acquisition loans [2] Integration and Synergy - The integration with Funmei Packaging is progressing smoothly, focusing on business collaboration and management to enhance both companies' operational capabilities and competitiveness in the sterile packaging industry. Long-term synergies are expected in product design, technology development, market layout, and operational management, creating greater value for shareholders and customers [3] - The company is implementing a strategic layout of "products + services + professionalism + innovation" in 2025, accelerating the construction of a production line for the "5 billion sterile packaging materials project" to enhance capacity and improve supply chain responsiveness. There will be a focus on cost control and management optimization, promoting standardization, proceduralization, and digitization of production and management processes to improve overall operational efficiency. The company aims to expand its market presence domestically and internationally to increase market share [3]
新巨丰(301296)：产能稳步扩张 期待协同效应释放